摘要
目的比较单独羊膜腔内注射乳酸依沙吖啶联合米非司酮中期引产的临床疗效。方法选取2014年1月~2017年1月我院收治的中期引产患者80例,随机分组,各40例,对照组单独羊膜腔内注射乳酸依沙吖啶,观察组基于对照组加用米非司酮,比较两组临床效果。结果观察组完全引产率为75.0%,不完全引产率为22.5%,失败率为2.5%,与对照组比较有显著性差异(P<0.05);观察组不良事件发生率为7.5%,低于对照组32.5%(P<0.05);观察组完全引产孕妇妊娠物排出时间明显短于对照组(P<0.05)。结论羊膜腔内注射乳酸依沙吖啶联用于米非司酮开展中期引产临床效果明显优于单独乳酸依沙吖啶,更具推广价值。
Objective To compare the clinical efcacy of intravesical injection of lactic acid eticridine and mifepristone in mid-term induction.Methods Eighty patients were randomly divided into two groupsthe control group （n=50）and the control group（n=50） were randomly divided into control group （n=50） And the clinical efcacy of the two groups was compared.Results The complete induction rate was 75.0%, the complete induction rate was 22.5%, the failure rate was 2.5%, and there was signifcant diference compared with the control group （P〈0.05）. The incidence of adverse events in the observation group was 7.5%, which was lower than that in the control group （32.5%, P〈0.05）. The discharge time of pregnant women was signifcantly shorter than that of the control group （P〈0.05）.Conclusion Amniocentric injection of lactic acid as an acridine acridine in the mid-term induction of mifepristone is superior to that of lactic acid alone,which is more popular.
出处
《实用妇科内分泌电子杂志》
2017年第8期59-60,共2页
Electronic Journal of Practical Gynecological Endocrinology
关键词
乳酸依沙吖啶
米非司酮
中期引产
Lactic acid acacridine
Mifepristone
Mid-term induction
